Deferred Income Tax Assets, Net of SINOVAC BIOTECH LTD from 31 Dec 2019 to 31 Dec 2023
- Taxonomy & unit
- us-gaap: USD
- Description
- Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.
- Summary
-
SINOVAC BIOTECH LTD quarterly Deferred Income Tax Assets, Net in USD history and change rate from 31 Dec 2019 to 31 Dec 2023.
- SINOVAC BIOTECH LTD Deferred Income Tax Assets, Net for the quarter ending 31 Dec 2023 was $29,790,000, a 58% decline year-over-year.
- Source SEC data
- View on sec.gov
Deferred Income Tax Assets, Net, Quarterly (USD)
Deferred Income Tax Assets, Net, YoY Quarterly Change (%)
SINOVAC BIOTECH LTD Quarterly Deferred Income Tax Assets, Net (USD)
| Period | Value | YoY Chg | Change % | Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|
| Q4 2023 | $29,790,000 | -$41,328,000 | -58% | 31 Dec 2023 | 20-F | 29 Apr 2024 | 2023 | FY |
| Q4 2022 | $71,118,000 | +$19,087,000 | +37% | 31 Dec 2022 | 20-F | 29 Apr 2024 | 2023 | FY |
| Q4 2021 | $52,031,000 | +$25,140,000 | +93% | 31 Dec 2021 | 20-F | 01 May 2023 | 2022 | FY |
| Q4 2020 | $26,891,000 | +$15,523,000 | +137% | 31 Dec 2020 | 20-F | 29 Apr 2022 | 2021 | FY |
| Q4 2019 | $11,368,000 | 31 Dec 2019 | 20-F | 22 Apr 2021 | 2020 | FY |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.